Add to ORKGGovernments try to regulate few markets as much as they do the pharma-ceutical market. They have to balance contrasting objectives. First, governments must secure health policy objectives: protecting public health; guaranteeing patient access to safe and effective medicines; improving the quality of care; an
This paper offers a theoretical perspective on pharmaceutical policy-making in the European Union, a...
This paper offers a theoretical perspective on pharmaceutical policy-making in the European Union, a...
Pharmaceuticals account for almost a fifth of total health spending in OECD-countries. Both pharmace...
The regulation of pharmaceutical markets is an important policy concern in many countries, and is ge...
The regulation of pharmaceutical markets is an important policy concern in many countries, and is ge...
The regulation of pharmaceutical markets is an important policy concern in many countries, and is ge...
This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
The establishment of the EMEA has been a revolutionary step in the European pharmaceutical system. T...
New prescription drugs are developed and tested for quality, safety, and efficacy by the pharmaceuti...
This paper offers a theoretical perspective on pharmaceutical policy-making in the European Union, a...
This paper offers a theoretical perspective on pharmaceutical policy-making in the European Union, a...
This paper offers a theoretical perspective on pharmaceutical policy-making in the European Union, a...
This paper offers a theoretical perspective on pharmaceutical policy-making in the European Union, a...
Pharmaceuticals account for almost a fifth of total health spending in OECD-countries. Both pharmace...
The regulation of pharmaceutical markets is an important policy concern in many countries, and is ge...
The regulation of pharmaceutical markets is an important policy concern in many countries, and is ge...
The regulation of pharmaceutical markets is an important policy concern in many countries, and is ge...
This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
The establishment of the EMEA has been a revolutionary step in the European pharmaceutical system. T...
New prescription drugs are developed and tested for quality, safety, and efficacy by the pharmaceuti...
This paper offers a theoretical perspective on pharmaceutical policy-making in the European Union, a...
This paper offers a theoretical perspective on pharmaceutical policy-making in the European Union, a...
This paper offers a theoretical perspective on pharmaceutical policy-making in the European Union, a...
This paper offers a theoretical perspective on pharmaceutical policy-making in the European Union, a...
Pharmaceuticals account for almost a fifth of total health spending in OECD-countries. Both pharmace...